In inflammatory bowel disease (IBD), aberrant macrophages (enriched for CD68+ and CD14hiCD16+ phenotypes) in the inflamed intestine promote cytokine production and delayed bacterial clearance, thereby promoting tissue injury and worsening disease outcome [7,16,17]. Here, CD68 is linked to inflammatory bowel disease.